Natasha Giordano
2017
In 2017, Natasha Giordano earned a total compensation of $963.6K as President and Chief Executive Officer at Dipexium Pharmaceuticals, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $185,000 |
|---|---|
| Option Awards | $358,747 |
| Salary | $400,000 |
| Other | $19,886 |
| Total | $963,633 |
Giordano received $400K in salary, accounting for 42% of the total pay in 2017.
Giordano also received $185K in non-equity incentive plan, $358.7K in option awards and $19.9K in other compensation.
Rankings
In 2017, Natasha Giordano's compensation ranked 9,150th out of 14,666 executives tracked by ExecPay. In other words, Giordano earned more than 37.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,150 out of 14,666 | 38th |
Division Manufacturing | 3,514 out of 5,768 | 39th |
Major group Chemicals And Allied Products | 1,203 out of 2,074 | 42nd |
Industry group Drugs | 964 out of 1,730 | 44th |
Industry Pharmaceutical Preparations | 756 out of 1,329 | 43rd |
Source: SEC filing on August 10, 2018.
Giordano's colleagues
We found two more compensation records of executives who worked with Natasha Giordano at Dipexium Pharmaceuticals in 2017.